查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2044425

數位神經精神平台市場預測至2034年—按平台類型、技術、應用、最終用戶和地區分類的全球分析

Digital Neuropsychiatry Platforms Market Forecasts to 2034 - Global Analysis By Platform Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球數位神經精神病學平台市場規模將達到 63.1 億美元，在預測期內以 23.8% 的複合年成長率成長，到 2034 年將達到 348.3 億美元。

數位神經精神平台是技術主導的解決方案，旨在透過數位化介面診斷、監測和治療精神和神經系統疾病。這些平台整合了遠端醫療、行動應用程式、基於人工智慧的評估和數位治療方法，為憂鬱症、焦慮症和認知障礙等疾病提供個人化護理。該市場涵蓋軟體平台、雲端基礎設施和服務供應商。市場成長的驅動力來自人們對心理健康意識的提高、對遠端醫療需求的成長以及數位治療方法的進步，這些因素共同促成了擴充性、可及且數據驅動的神經精神護理方法。

虛擬心理健康護理的廣泛應用

虛擬心理健康服務的日益普及正顯著推動數位神經精神病學平台市場的發展。人們對心理健康的日益關注，以及對便捷精神科諮詢的需求，正在加速數位平台的普及。此外，由於遠距就診的便利性和減少社會歧視，患者越來越傾向於選擇遠距就診。同時，醫療服務提供者也將安全的遠距神經精神科系統整合到日常診療流程中。隨著全球寬頻普及率和智慧型手機使用量的不斷成長，虛擬精神科諮詢服務正持續高效擴展，進一步增強了整體市場的發展動能。

跨境授權法規

跨境醫療執業許可的相關規定為遠距精神醫學生態系統帶來了結構上的複雜性。精神科醫生通常需要獲得額外的認證才能在多個州或國際範圍內提供服務。此外，遠端醫療合規框架的區域差異也給服務提供者帶來了行政負擔。資料隱私義務和各司法管轄區的醫療保健政策進一步影響了服務的擴充性。儘管如此，協調法規和州際協議的努力正在逐步簡化服務的流動性。隨著政策的現代化，跨境精神科服務的提供有望變得更加標準化。

人工智慧遠距離診斷

人工智慧驅動的遠距離診斷工具正在為數位神經精神病學平台創造變革性的機會。先進的機器學習演算法能夠透過數位化評估，早期發現情緒障礙、認知衰退和行為異常。此外，自然語言處理技術增強了線上諮詢中的臨床評估。這些功能提高了診斷準確性和病患監測效率。醫療系統正擴大採用人工智慧分診系統來最佳化臨床醫生的工作量。因此，智慧自動化增強了遠距神經精神病學解決方案的擴充性，並擴大了其臨床價值。

與通用遠距遠端醫療平台的競爭

來自更廣泛的遠端醫療平台的競爭正在影響高度專業化的遠距精神病學領域。多學科數位醫療服務提供者正在將行為醫學模組整合到全面的虛擬醫療生態系統中。此外，成熟的遠端醫療品牌正在利用其強大的用戶覆蓋率和雄厚的資金實力。這使得專注於特定領域的神經精神病學平台的競爭差異化要求更加嚴格。然而，神經病學和精神病學整合方面的專業知識仍然是一項策略優勢。那些強調特定認知和行為專業知識的平台，透過提供專注的服務，持續保持競爭優勢。

新冠疫情的影響：

新冠疫情顯著加速了數位化神經精神醫學平台的普及。封鎖和社交距離的措施限制了面對面的精神科諮詢，促使人們迅速轉向線上診療。醫療監管機構暫時放寬了對遠端醫療的限制，推動了更廣泛的線上諮詢。同時，隨著焦慮、憂鬱症和壓力相關疾病的增加，人們對心理健康服務的需求也隨之成長。在此期間，對數位行為醫學新創企業的投資也大幅增加。疫情最終重塑了長期精神科護理服務模式，使遠距精神科成為主流醫療保健基礎設施。

在預測期內，基於雲端的遠距精神病學平台細分市場預計將成為最大的細分市場。

在預測期內，基於雲端的遠距精神科平台預計將佔據最大的市場佔有率。雲端技術的應用實現了擴充性的基礎設施、安全的資料儲存以及與電子健康記錄的無縫整合。此外，訂閱模式提高了診所和醫院的成本效益。即時視訊會議、加密通訊和分析儀錶板等功能提升了營運效率。隨著醫療服務提供者優先考慮靈活且可互通的解決方案，雲端平台將繼續在整體應用方面保持主導地位。

預計在預測期內，基於人工智慧的臨床決策支援領域將呈現最高的複合年成長率。

在預測期內，基於人工智慧的臨床決策支援領域預計將呈現最高的成長率。智慧系統透過預測分析和結果建模來輔助精神科醫生製定治療方案。此外，演算法洞察能夠改善藥物管理和最佳化治療方法。持續的數據學習能夠隨著時間的推移提高準確性。醫療機構正擴大採用人工智慧平台來加強實證醫療服務。因此，強大的技術整合正在推動該領域的快速發展。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。該地區強大的數位醫療基礎設施、優惠的報銷政策以及較高的心理健康意識，都支撐著強勁的需求。此外，大量的創業投資資金籌措正在加速遠距神經精神病學新創企業的創新。學術研究機構正積極與科技公司合作，以改善數位精神醫學工具。這些因素共同鞏固了北美在虛擬神經精神病學醫療服務領域的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。快速的都市化、不斷擴大的網路連線以及人們對心理健康意識的日益增強，正在推動遠距醫療的普及。各國政府正在加強遠端醫療框架建設，以改善農村地區的醫療服務可近性。此外，智慧型手機普及率的不斷提高也加速了行動精神科醫療服務的發展。醫療服務提供者正在投資開發在地化的數位健康平台，以滿足其人口規模的需求。這些有利的人口結構和技術發展趨勢，正使亞太地區成為一個高成長區域。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球數位神經精神醫學平台市場：依平台類型分類

  • 基於雲端的遠距精神科平台
  • 行動遠距精神病學應用
  • 網路為基礎的諮詢平台
  • 整合式電子病歷平台
  • 人工智慧輔助診斷平台
  • 遠端監測和評估平台
  • 混合虛擬醫療平台

第6章 全球數位神經精神醫學平台市場：依技術分類

  • 人工智慧驅動的臨床決策支持
  • 遠端患者監護工具
  • 安全的視訊會議系統
  • 數位處方箋與電子病歷的整合
  • 雲端和資料安全解決方案
  • 互通性和API框架

第7章 全球數位神經精神醫學平台市場：按應用分類

  • 憂鬱症與焦慮症的治療
  • 思覺失調症和精神病性障礙
  • 雙極性情感障礙的治療
  • 注意力不足過動症和行為障礙
  • 物質使用疾患的治療
  • 創傷後壓力症候群（PTSD）

第8章 全球數位神經精神醫學平台市場：依最終用戶分類

  • 醫院及精神健康診所
  • 私人精神科診所
  • 遠端醫療服務供應商
  • 居家醫療環境
  • 政府醫療保健計劃
  • 企業健康計劃

第9章 全球數位神經精神醫學平台市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Teladoc Health, Inc.
  • Amwell（American Well Corporation）
  • MDLIVE Inc.
  • Doxy.me Inc.
  • Talkspace, Inc.
  • BetterHelp（Teladoc Health, Inc.）
  • Doctor On Demand, Inc.
  • Lyra Health, Inc.
  • Ginger（Headspace Health）
  • Cerebral Inc.
  • Spring Health
  • Mindstrong Health
  • InTouch Health
  • Zoom Video Communications, Inc.
  • Oracle Cerner
  • Allscripts Healthcare Solutions, Inc.
  • Athenahealth, Inc.
  • Epic Systems Corporation
Product Code: SMRC36214

According to Stratistics MRC, the Global Digital Neuropsychiatry Platforms Market is accounted for $6.31 billion in 2026 and is expected to reach $34.83 billion by 2034 growing at a CAGR of 23.8% during the forecast period. Digital neuropsychiatry platforms are technology-driven solutions designed to diagnose, monitor, and treat mental health and neurological conditions through digital interfaces. These platforms integrate telemedicine, mobile applications, AI-based assessments, and digital therapeutics to provide personalized care for conditions such as depression, anxiety, and cognitive disorders. The market includes software platforms, cloud infrastructure, and service providers. Growth is fueled by increasing mental health awareness, rising demand for remote healthcare, and advancements in digital therapeutics, enabling scalable, accessible, and data-driven approaches to neuropsychiatric care.

Market Dynamics:

Driver:

Rising virtual mental healthcare adoption

The growing acceptance of virtual mental healthcare services is significantly driving the Digital Neuropsychiatry Platforms Market. Increasing awareness regarding mental health, coupled with demand for accessible psychiatric consultations, has accelerated digital platform utilization. Moreover, patients are increasingly preferring remote sessions due to convenience and reduced stigma. Healthcare providers are simultaneously integrating secure tele-neuropsychiatry systems into routine care pathways. As broadband penetration and smartphone adoption expand globally, virtual psychiatric engagement continues to scale efficiently, strengthening overall market momentum.

Restraint:

Cross-border licensing restrictions

Cross-border medical licensing regulations present structural complexities within the tele-neuropsychiatry ecosystem. Psychiatric practitioners are often required to obtain separate certifications for multi-state or international consultations. Furthermore, varying telemedicine compliance frameworks create administrative burdens for service providers. Data privacy mandates and jurisdiction-specific healthcare policies further influence operational scalability. Nevertheless, regulatory harmonization efforts and interstate compacts are gradually streamlining practice mobility. As policy modernization progresses, cross-border psychiatric service delivery is expected to become more standardized.

Opportunity:

AI-assisted remote diagnosis

AI-assisted remote diagnostic tools are creating transformative opportunities in Digital Neuropsychiatry Platforms. Advanced machine learning algorithms are enabling early detection of mood disorders, cognitive decline, and behavioral abnormalities through digital assessments. Additionally, natural language processing enhances clinical evaluation during virtual consultations. These capabilities improve diagnostic precision and patient monitoring efficiency. Healthcare systems are increasingly integrating AI-enabled triage systems to optimize clinician workload. Consequently, intelligent automation is strengthening scalability and expanding the clinical value proposition of tele-neuropsychiatry solutions.

Threat:

General telehealth platform competition

Competition from broader telehealth platforms is influencing the specialized tele-neuropsychiatry landscape. Multi-specialty digital health providers are incorporating behavioral health modules within comprehensive virtual care ecosystems. Furthermore, established telemedicine brands leverage strong consumer reach and capital resources. This intensifies competitive differentiation requirements for niche neuropsychiatry platforms. However, specialization in neurological and psychiatric integration remains a strategic advantage. Platforms emphasizing targeted cognitive and behavioral expertise continue to maintain competitive positioning through focused service delivery.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated adoption of Digital Neuropsychiatry Platforms. Lockdowns and social distancing measures limited in-person psychiatric consultations, prompting rapid digital transition. Healthcare regulators temporarily eased telemedicine restrictions, facilitating broader virtual engagement. Simultaneously, rising anxiety, depression, and stress-related conditions increased demand for mental health services. Investment inflows into digital behavioral health startups expanded during this period. The pandemic ultimately reshaped long-term psychiatric care delivery models, embedding tele-neuropsychiatry into mainstream healthcare infrastructure.

The cloud-based telepsychiatry platforms segment is expected to be the largest during the forecast period

The cloud-based telepsychiatry platforms segment is expected to account for the largest market share during the forecast period. Cloud deployment enables scalable infrastructure, secure data storage, and seamless integration with electronic health records. Moreover, subscription-based models support cost efficiency for clinics and hospitals. Real-time video conferencing, encrypted communication, and analytics dashboards enhance operational performance. As healthcare providers prioritize flexible and interoperable solutions, cloud-based platforms continue to dominate overall adoption.

The AI-based clinical decision support segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-based clinical decision support segment is predicted to witness the highest growth rate. Intelligent systems assist psychiatrists in treatment planning through predictive analytics and outcome modeling. Additionally, algorithm-driven insights enhance medication management and therapy optimization. Continuous data learning improves accuracy over time. Healthcare institutions are increasingly adopting AI-enabled platforms to enhance evidence-based care delivery. Consequently, strong technological integration is driving rapid expansion within this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. Advanced digital health infrastructure, favorable reimbursement policies, and high mental health awareness support strong regional demand. Furthermore, substantial venture capital funding accelerates innovation across tele-neuropsychiatry startups. Academic research institutions actively collaborate with technology firms to refine digital psychiatric tools. These factors collectively reinforce North America's leadership in virtual neuropsychiatric care delivery.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization, expanding internet connectivity, and increasing mental health awareness are driving adoption. Governments are strengthening telemedicine frameworks to improve rural healthcare accessibility. Additionally, rising smartphone penetration facilitates mobile-based psychiatric consultations. Healthcare providers are investing in localized digital health platforms to address population-scale demand. These favorable demographic and technological trends position Asia Pacific as a high-growth region.

Key players in the market

Some of the key players in Digital Neuropsychiatry Platforms Market include The telemedicine and digital health landscape includes key players such as Teladoc Health, Inc., Amwell (American Well Corporation), MDLIVE Inc., Doxy.me Inc., Talkspace, Inc., BetterHelp (Teladoc Health, Inc.), Doctor On Demand, Inc., Lyra Health, Inc., Ginger (Headspace Health), Cerebral Inc., Spring Health, Mindstrong Health, InTouch Health, Zoom Video Communications, Inc., Oracle Cerner, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., and Epic Systems Corporation.

Key Developments:

In February 2026, Teladoc Health, Inc. introduced its AI-Enhanced Neuropsychiatry Telehealth Suite, designed to provide real-time cognitive assessments and therapy sessions. The platform integrates advanced analytics to personalize treatment pathways for patients with neurological and psychiatric conditions.

In Janyuary 2026, Amwell launched its Virtual Neuropsychiatry Care Platform, enabling simplified access to licensed specialists. The system supports secure video consultations, digital prescriptions, and integrated patient monitoring tools for improved continuity of care in mental health management.

Platform Types Covered:

  • Cloud-Based Telepsychiatry Platforms
  • Mobile Tele-Neuropsychiatry Applications
  • Web-Based Consultation Platforms
  • Integrated EHR-Enabled Platforms
  • AI-Assisted Diagnostic Platforms
  • Remote Monitoring & Assessment Platforms
  • Hybrid Virtual Care Platforms

Technologies Covered:

  • AI-Based Clinical Decision Support
  • Remote Patient Monitoring Tools
  • Secure Video Conferencing Systems
  • Digital Prescription & EHR Integration
  • Cloud & Data Security Solutions
  • Interoperability & API Frameworks

Applications Covered:

  • Depression & Anxiety Management
  • Schizophrenia & Psychotic Disorders
  • Bipolar Disorder Treatment
  • ADHD & Behavioral Disorders
  • Substance Use Disorder Treatment
  • Post-Traumatic Stress Disorder (PTSD)

End Users Covered:

  • Hospitals & Mental Health Clinics
  • Private Psychiatry Practices
  • Telehealth Service Providers
  • Homecare Settings
  • Government Health Programs
  • Corporate Wellness Programs

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 3032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Digital Neuropsychiatry Platforms Market, By Platform Type

  • 5.1 Cloud-Based Telepsychiatry Platforms
  • 5.2 Mobile Tele-Neuropsychiatry Applications
  • 5.3 Web-Based Consultation Platforms
  • 5.4 Integrated EHR-Enabled Platforms
  • 5.5 AI-Assisted Diagnostic Platforms
  • 5.6 Remote Monitoring & Assessment Platforms
  • 5.7 Hybrid Virtual Care Platforms

6 Global Digital Neuropsychiatry Platforms Market, By Technology

  • 6.1 AI-Based Clinical Decision Support
  • 6.2 Remote Patient Monitoring Tools
  • 6.3 Secure Video Conferencing Systems
  • 6.4 Digital Prescription & EHR Integration
  • 6.5 Cloud & Data Security Solutions
  • 6.6 Interoperability & API Frameworks

7 Global Digital Neuropsychiatry Platforms Market, By Application

  • 7.1 Depression & Anxiety Management
  • 7.2 Schizophrenia & Psychotic Disorders
  • 7.3 Bipolar Disorder Treatment
  • 7.4 ADHD & Behavioral Disorders
  • 7.5 Substance Use Disorder Treatment
  • 7.6 Post-Traumatic Stress Disorder (PTSD)

8 Global Digital Neuropsychiatry Platforms Market, By End User

  • 8.1 Hospitals & Mental Health Clinics
  • 8.2 Private Psychiatry Practices
  • 8.3 Telehealth Service Providers
  • 8.4 Homecare Settings
  • 8.5 Government Health Programs
  • 8.6 Corporate Wellness Programs

9 Global Digital Neuropsychiatry Platforms Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Teladoc Health, Inc.
  • 12.2 Amwell (American Well Corporation)
  • 12.3 MDLIVE Inc.
  • 12.4 Doxy.me Inc.
  • 12.5 Talkspace, Inc.
  • 12.6 BetterHelp (Teladoc Health, Inc.)
  • 12.7 Doctor On Demand, Inc.
  • 12.8 Lyra Health, Inc.
  • 12.9 Ginger (Headspace Health)
  • 12.10 Cerebral Inc.
  • 12.11 Spring Health
  • 12.12 Mindstrong Health
  • 12.13 InTouch Health
  • 12.14 Zoom Video Communications, Inc.
  • 12.15 Oracle Cerner
  • 12.16 Allscripts Healthcare Solutions, Inc.
  • 12.17 Athenahealth, Inc.
  • 12.18 Epic Systems Corporation

List of Tables

  • Table 1 Global Digital Neuropsychiatry Platforms Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Digital Neuropsychiatry Platforms Market Outlook, By Platform Type (2023-2034) ($MN)
  • Table 3 Global Digital Neuropsychiatry Platforms Market Outlook, By Cloud-Based Telepsychiatry Platforms (2023-2034) ($MN)
  • Table 4 Global Digital Neuropsychiatry Platforms Market Outlook, By Mobile Tele-Neuropsychiatry Applications (2023-2034) ($MN)
  • Table 5 Global Digital Neuropsychiatry Platforms Market Outlook, By Web-Based Consultation Platforms (2023-2034) ($MN)
  • Table 6 Global Digital Neuropsychiatry Platforms Market Outlook, By Integrated EHR-Enabled Platforms (2023-2034) ($MN)
  • Table 7 Global Digital Neuropsychiatry Platforms Market Outlook, By AI-Assisted Diagnostic Platforms (2023-2034) ($MN)
  • Table 8 Global Digital Neuropsychiatry Platforms Market Outlook, By Remote Monitoring & Assessment Platforms (2023-2034) ($MN)
  • Table 9 Global Digital Neuropsychiatry Platforms Market Outlook, By Hybrid Virtual Care Platforms (2023-2034) ($MN)
  • Table 10 Global Digital Neuropsychiatry Platforms Market Outlook, By Technology (2023-2034) ($MN)
  • Table 11 Global Digital Neuropsychiatry Platforms Market Outlook, By AI-Based Clinical Decision Support (2023-2034) ($MN)
  • Table 12 Global Digital Neuropsychiatry Platforms Market Outlook, By Remote Patient Monitoring Tools (2023-2034) ($MN)
  • Table 13 Global Digital Neuropsychiatry Platforms Market Outlook, By Secure Video Conferencing Systems (2023-2034) ($MN)
  • Table 14 Global Digital Neuropsychiatry Platforms Market Outlook, By Digital Prescription & EHR Integration (2023-2034) ($MN)
  • Table 15 Global Digital Neuropsychiatry Platforms Market Outlook, By Cloud & Data Security Solutions (2023-2034) ($MN)
  • Table 16 Global Digital Neuropsychiatry Platforms Market Outlook, By Interoperability & API Frameworks (2023-2034) ($MN)
  • Table 17 Global Digital Neuropsychiatry Platforms Market Outlook, By Application (2023-2034) ($MN)
  • Table 18 Global Digital Neuropsychiatry Platforms Market Outlook, By Depression & Anxiety Management (2023-2034) ($MN)
  • Table 19 Global Digital Neuropsychiatry Platforms Market Outlook, By Schizophrenia & Psychotic Disorders (2023-2034) ($MN)
  • Table 20 Global Digital Neuropsychiatry Platforms Market Outlook, By Bipolar Disorder Treatment (2023-2034) ($MN)
  • Table 21 Global Digital Neuropsychiatry Platforms Market Outlook, By ADHD & Behavioral Disorders (2023-2034) ($MN)
  • Table 22 Global Digital Neuropsychiatry Platforms Market Outlook, By Substance Use Disorder Treatment (2023-2034) ($MN)
  • Table 23 Global Digital Neuropsychiatry Platforms Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2023-2034) ($MN)
  • Table 24 Global Digital Neuropsychiatry Platforms Market Outlook, By End User (2023-2034) ($MN)
  • Table 25 Global Digital Neuropsychiatry Platforms Market Outlook, By Hospitals & Mental Health Clinics (2023-2034) ($MN)
  • Table 26 Global Digital Neuropsychiatry Platforms Market Outlook, By Private Psychiatry Practices (2023-2034) ($MN)
  • Table 27 Global Digital Neuropsychiatry Platforms Market Outlook, By Telehealth Service Providers (2023-2034) ($MN)
  • Table 28 Global Digital Neuropsychiatry Platforms Market Outlook, By Homecare Settings (2023-2034) ($MN)
  • Table 29 Global Digital Neuropsychiatry Platforms Market Outlook, By Government Health Programs (2023-2034) ($MN)
  • Table 30 Global Digital Neuropsychiatry Platforms Market Outlook, By Corporate Wellness Programs (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.